Sponsored by
Impressive long term survival state presented at the SNO conference of Rindopepimut plus Avastin vs. Avastin alone for recurrent Glioblastoma patients. Highlight: at 2 years the Rindopeimut + Avastin group had 25% of patients alive. The Avastin alone group had 0% alive.
This is just a simple shot in the arm which adds no significant side effects - just local reaction at the injection site like a flu shot.